Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs
Open accessThe DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
IFITMs are broad antiviral factors that block incoming virions in endosomal vesicles, protecting target cells from infection. In the case of HIV-1, we and others reported the existence of an additional antiviral mechanism through which IFITMs lead to the production of virions of reduced infectivity. However, whether this second mechanism of inhibition is unique to HIV or extends to other viruses is currently unknown. To address this question, we have analyzed the susceptibility of a broad spectrum of viruses to the negative imprinting of the virion particles infectivity by IFITMs. The results we have gathered indicate that this second antiviral property of IFITMs extends well beyond HIV and we were able to identify viruses susceptible to the three IFITMs altogether (HIV-1, SIV, MLV, MPMV, VSV, MeV, EBOV, WNV), as well as viruses that displayed a member-specific susceptibility (EBV, DUGV), or were resistant to all IFITMs (HCV, RVFV, MOPV, AAV). The swapping of genetic elements between resistant and susceptible viruses allowed us to point to specificities in the viral mode of assembly, rather than glycoproteins as dominant factors of susceptibility. However, we also show that, contrarily to X4-, R5-tropic HIV-1 envelopes confer resistance against IFITM3, suggesting that viral receptors add an additional layer of complexity in the IFITMs-HIV interplay. Lastly, we show that the overall antiviral effects ascribed to IFITMs during spreading infections, are the result of a bimodal inhibition in which IFITMs act both by protecting target cells from incoming viruses and in driving the production of virions of reduced infectivity. Overall, our study reports for the first time that the negative imprinting of the virion particles infectivity is a conserved antiviral property of IFITMs and establishes IFITMs as a paradigm of restriction factor capable of interfering with two distinct phases of a virus life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IFITM proteins are broad antiviral factors that inhibit viral entry and exit for HIV-1, SIV, MLV, VSV, EBOV, WNV, among other viruses69.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [69]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511 · cited 1×
“This trick allows a very efficient transduction of myeloid cells by HIV-1 [88] [89] [90] thanks to the reported ability of Vpx to remove the restriction factor SAMHD1 [91, 92] .”
BackgroundTsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding
Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G., Zavitz, K. H., Wang, H. E., Wettstein, D. A., Stray, K. M., Côté, M., Rich, R. L., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00506-2 · Cited by 1,369 · cited 1×
“These results are intriguing because MLV and especially MPMV display assembly specificities that are distinct from lentiviruses, although they ultimately acquire a plasma membrane-derived envelope [56, 57, 58] .”
ResultBrass, A. L., Huang, I.-C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.017 · Cited by 1,269
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200 · cited 1×
“This trick allows a very efficient transduction of myeloid cells by HIV-1 [88] [89] [90] thanks to the reported ability of Vpx to remove the restriction factor SAMHD1 [91, 92] .”
BackgroundInfectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes
Bartosch, B., Dubuisson, J., & Cosset, F.-L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021756 · Cited by 1,111
IFITM3 restricts the morbidity and mortality associated with influenza
The GenISIS Investigators, Everitt, A. R., The MOSAIC Investigators, Clare, S., Pertel, T., John, S. P., Wash, R. S., Smith, S. E., Chin, C. R., Feeley, E. M., et al. (2012) · Nature · doi:10.1038/nature10921 · Cited by 782
Friedman, R. L., Manly, S. P., McMahon, M., Kerr, I. M., & Stark, G. R. (1984) · Cell · doi:10.1016/0092-8674(84)90270-8 · Cited by 718
HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes
Miyauchi, K., Kim, Y., Latinovic, O., Morozov, V., & Melikyan, G. B. (2009) · Cell · doi:10.1016/j.cell.2009.02.046 · Cited by 681
Cited by
IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections
Zhao, X., Li, J., Winkler, C. A., An, P., & Guo, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03228 · Cited by 164
IFITM proteins: Understanding their diverse roles in viral infection, cancer, and immunity
Gómez-Herranz, M., Taylor, J., & Sloan, R. D. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102741 · Cited by 131
Shi, G., Schwartz, O., & Compton, A. A. (2017) · Retrovirology · doi:10.1186/s12977-017-0377-y · Cited by 109
Chemudupati, M., Kenney, A. D., Bonifati, S., Zani, A., McMichael, T. M., Wu, L. J., & Yount, J. S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.09.012 · Cited by 102
Guo, X., Steinkühler, J., Marin, M., Li, X., Lu, W., Dimova, R., & Melikyan, G. B. (2021) · ACS Nano · doi:10.1021/acsnano.0c10567 · Cited by 96
Suddala, K. C., Lee, C. C., Meraner, P., Marin, M., Markosyan, R. M., Desai, T. M., Cohen, F. S., Brass, A. L., & Melikyan, G. B. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007532 · Cited by 88
IFITM proteins inhibit HIV-1 protein synthesis
Lee, W.-Y. J., Fu, R., Liang, C., & Sloan, R. D. (2018) · Scientific Reports · doi:10.1038/s41598-018-32785-5 · Cited by 87
Antiviral Protection by IFITM3 In Vivo
Zani, A., & Yount, J. S. (2018) · Current Clinical Microbiology Reports · doi:10.1007/s40588-018-0103-0 · Cited by 84
Functional Involvement of Interferon-Inducible Transmembrane Proteins in Antiviral Immunity
Liao, Y., Goraya, M. U., Xu, Y., Zhang, B., Chiu, S.-H., & Chen, J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01097 · Cited by 84
Rahman, K., Coomer, C. A., Majdoul, S., Ding, S. Y., Padilla‐Parra, S., & Compton, A. A. (2020) · eLife · doi:10.7554/elife.58537 · Cited by 74
Distinct Effects of Type I and III Interferons on Enteric Viruses
Ingle, H., Peterson, S. T., & Baldridge, M. T. (2018) · Viruses · doi:10.3390/v10010046 · Cited by 62
Interferon system deficiencies exacerbating severe pandemic virus infections
Stertz, S., & Hale, B. G. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2021.03.001 · Cited by 62
Feng, J., Wickenhagen, A., Turnbull, M. L., Rezelj, V. V., Kreher, F., Tilston‐Lunel, N. L., Slack, G. S., Brennan, B., Koudriakova, E., Shaw, A. E., et al. (2018) · Journal of Virology · doi:10.1128/jvi.02140-17 · Cited by 59
Interplay between Intrinsic and Innate Immunity during HIV Infection
Bergantz, L., Subra, F., Deprez, E., Delelis, O., & Richetta, C. (2019) · Cells · doi:10.3390/cells8080922 · Cited by 48
Zhang, A., Duan, H. Q., Zhao, H., Liao, H., Du, Y., Li, L., Jiang, D., Wan, B., Wu, Y., Ji, P., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01350-20 · Cited by 48
IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag
Ahi, Y. S., Yimer, D., Shi, G., Majdoul, S., Rahman, K., Rein, A. R., & Compton, A. A. (2020) · mBio · doi:10.1128/mbio.03088-19 · Cited by 46
The Role of IFITM Proteins in Tick-Borne Encephalitis Virus Infection
Chmielewska, A., Gómez-Herranz, M., Gach, P., Nekulová, M., Bagnucka, M. A., Lipińska, A. D., Rychłowski, M., Hoffmann, W., Król, E., Vojtěšek, B., et al. (2021) · Journal of Virology · doi:10.1128/jvi.01130-21 · Cited by 37
D’Urbano, V., Crignis, E. D., & Re, M. C. (2018) · Current HIV Research · doi:10.2174/1570162x16666180817115830 · Cited by 36
Meischel, T., Fritzlar, S., Villalón‐Letelier, F., Tessema, M. B., Brööks, A. G., Reading, P. C., & Londrigan, S. L. (2021) · Journal of Virology · doi:10.1128/jvi.00837-21 · Cited by 35
Wang, Q., & Su, L. (2019) · mBio · doi:10.1128/mbio.01344-19 · Cited by 34
Immunity and Viral Infections: Modulating Antiviral Response via CRISPR–Cas Systems
Brezgin, S. A., Kostyusheva, A. P., Олеговна, Б. Е., Volchkova, E. V., Gegechkori, V., Gordeychuk, I. V., Glebe, D., Kostyushev, D. S., & Chulanov, V. (2021) · Viruses · doi:10.3390/v13071373 · Cited by 31
Interferon-stimulated genes and their antiviral activity against SARS-CoV-2
Ortega‐Prieto, A. M., & Jiménez-Guardeño, J. M. (2024) · mBio · doi:10.1128/mbio.02100-24 · Cited by 29
Appourchaux, R., Delpeuch, M., Li, Z., Burlaud‐Gaillard, J., Tartour, K., Savidis, G., Brass, A. L., Etienne, L., Roingeard, P., & Cimarelli, A. (2018) · Journal of Virology · doi:10.1128/jvi.01716-18 · Cited by 29
Self-citationFranz, S., Zillinger, T., Pott, F., Schüler, C., Dapa, S., Fischer, C., Passos, V., Stenzel, S., Chen, F., Döhner, K., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000909 · Cited by 29
Interferon‐inducible phospholipids govern IFITM3‐dependent endosomal antiviral immunity
Unali, G., Crivicich, G., Pagani, I., Alezz, M. A., Folchini, F., Valeri, E., Matafora, V., Reisz, J. A., Giordano, A. M. S., Cuccovillo, I., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022112234 · Cited by 27
HIV-1 Envelope Glycoprotein at the Interface of Host Restriction and Virus Evasion
Beitari, S., Wang, Y., Liu, S., & Liang, C. (2019) · Viruses · doi:10.3390/v11040311 · Cited by 27
The Antiviral Activity of Interferon-Induced Transmembrane Proteins and Virus Evasion Strategies
Wang, J., Luo, Y., Katiyar, H., Liang, C., & Liu, Q. (2024) · Viruses · doi:10.3390/v16050734 · Cited by 26
Foster, T. L., Pickering, S., & Neil, S. J. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01853 · Cited by 26
Toward a Macaque Model of HIV-1 Infection: Roadblocks, Progress, and Future Strategies
Thippeshappa, R., Kimata, J. T., & Kaushal, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00882 · Cited by 26
West Nile Virus Restriction in Mosquito and Human Cells: A Virus under Confinement
Martin, M. F., & Nisole, S. (2020) · Vaccines · doi:10.3390/vaccines8020256 · Cited by 26
IFITM3 incorporation sensitizes influenza A virus to antibody-mediated neutralization
Lanz, C., Schotsaert, M., Magnus, C., Karakus, U., Hunziker, A., Borau, M. S., Martínez‐Romero, C., Spieler, E. E., Günther, S. C., Moritz, E., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20200303 · Cited by 25
Discovery of Genes that Modulate Flavivirus Replication in an Interferon-Dependent Manner
Lesage, S., Chazal, M., Beauclair, G., Batalie, D., Cerboni, S., Couderc, É., Lescure, A., Nery, E. D., Tangy, F., Martin, A., et al. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167277 · Cited by 24
Membrane Interference Against HIV-1 by Intrinsic Antiviral Factors: The Case of IFITMs
Marziali, F., & Cimarelli, A. (2021) · Cells · doi:10.3390/cells10051171 · Cited by 22
Self-citationVavougios, G. D., Mavridis, T., Artemiadis, A., Krogfelt, K. A., & Hadjigeorgiou, G. M. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166430 · Cited by 21
Wang, Y., Fu, Q., Park, S. Y., Lee, Y. S., Park, S., Lee, D., & Yoon, S. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2024.108322 · Cited by 21
Yu, J., & Liu, S. (2018) · Viruses · doi:10.3390/v10080413 · Cited by 21
Escape of HIV-1 Envelope Glycoprotein from Restriction of Infection by IFITM3
Drouin, A., Migraine, J., Durand, M.-A., Moreau, A., Burlaud‐Gaillard, J., Beretta, M., Roingeard, P., Bouvin-Pley, M., & Braibant, M. (2020) · Journal of Virology · doi:10.1128/jvi.01994-20 · Cited by 18
Self-citationFunctional Heterogeneity of Mammalian IFITM Proteins against HIV-1
Marziali, F., Delpeuch, M., Kumar, A., Appourchaux, R., Dufloo, J., Tartour, K., Etienne, L., & Cimarelli, A. (2021) · Journal of Virology · doi:10.1128/jvi.00439-21 · Cited by 17
Self-citationMurakami, T., & Ono, A. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.07.005 · Cited by 16
Antiviral role of IFITM3 in prototype foamy virus infection
Wang, Z., Tuo, X., Zhang, J., Chai, K., Tan, J., & Qiao, W. (2022) · Virology Journal · doi:10.1186/s12985-022-01931-x · Cited by 16
Role of Type I Interferons during Mycobacterium tuberculosis and HIV Infections
Anes, E., Azevedo‐Pereira, J. M., & Pires, D. (2024) · Biomolecules · doi:10.3390/biom14070848 · Cited by 15
Hörnich, B. F., Großkopf, A. K., Dcosta, C. J., Schlagowski, S., & Hahn, A. S. (2021) · mBio · doi:10.1128/mbio.02113-21 · Cited by 15
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages
Virgilio, M. C., Ramnani, B., Chen, T., Disbennett, W. M., Lubow, J., Welch, J. D., & Collins, K. L. (2024) · Nature Communications · doi:10.1038/s41467-024-49635-w · Cited by 14
Rashid, F., Zaongo, S. D., Iqbal, H., Harypursat, V., Song, F., & Chen, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1390650 · Cited by 14
Role of Viral Envelope Proteins in Determining Susceptibility of Viruses to IFITM Proteins
Marceau, T., & Braibant, M. (2024) · Viruses · doi:10.3390/v16020254 · Cited by 11
Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats
Mak, N. S. C., Liu, J., Zhang, D., Taylor, J., Li, X., Rahman, K., Chen, F., Datta, S. A. K., Lai, K. K., Shi, Z., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012763 · Cited by 10
Interferon–Inducible Transmembrane Protein 3 (IFITM3) Restricts Rotavirus Infection
Pang, Z., Hao, P., Qu, Q., Li, L., Jiang, Y., Xiao, S., Jin, N., & Li, C. (2022) · Viruses · doi:10.3390/v14112407 · Cited by 10
Verma, S., Chen, Y.-C., Marin, M., Gillespie, S. E., & Melikyan, G. B. (2023) · Viruses · doi:10.3390/v15122390 · Cited by 10
Cai, S., Zheng, Z., Cheng, J., Zhong, L., Shao, R., Zheng, F., Lai, Z., Ou, J., Xu, L., Zhou, P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.827709 · Cited by 10
Zhang, L., Yang, G., Wang, J., Zhang, J., Chen, K., Xiong, X., Zhu, Y., Xu, C., & Wang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108637 · Cited by 9
Uncovering the evolving arms race between host immunity and HIV-1
Song, Y.-H., Kim, H., Baur, A. S., & Lee, J. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.08.004 · Cited by 7
Help or Hinder: Protein Host Factors That Impact HIV-1 Replication
Moezpoor, M. R., & Stevenson, M. (2024) · Viruses · doi:10.3390/v16081281 · Cited by 7
Confort, M.-P., Duboeuf, M., Thiesson, A., Pons, L., Marziali, F., Desloire, S., Ratinier, M., Cimarelli, A., & Arnaud, F. (2023) · Viruses · doi:10.3390/v15020306 · Cited by 6
Self-citationPřikryl, D., Marin, M., Desai, T. M., Du, Y., Fu, H., & Melikyan, G. B. (2023) · Biomolecules · doi:10.3390/biom13060937 · Cited by 4
Marziali, F., Song, Y., Nguyen, X.-N., Belmudes, L., Burlaud‐Gaillard, J., Roingeard, P., Couté, Y., & Cimarelli, A. (2023) · Viruses · doi:10.3390/v15101993 · Cited by 2
Self-citationHost RNA-Binding Proteins as Regulators of HIV-1 Replication
Giraldo-Ocampo, S., Valiente‐Echeverría, F., & Soto‐Rifo, R. (2024) · Viruses · doi:10.3390/v17010043 · Cited by 2
Marceau, T., Migraine, J., Moreau, A., Arrouche, Y., Andriantsoanirina, V., Verrier, B., Mammano, F., Meyer, L., & Braibant, M. (2025) · AIDS · doi:10.1097/qad.0000000000004304 · Cited by 1
Verma, S., Přikryl, D., Marin, M., Markosyan, R. M., Cimarelli, A., & Melikyan, G. B. (2026) · Biomolecules · doi:10.3390/biom16030459 · Cited by 1
Self-citationInterferon-induced transmembrane proteins in cancer and virus biology: a membrane perspective
Xia, T., & Cimarelli, A. (2026) · mBio · doi:10.1128/mbio.00784-26 · Cited by 1
Self-citationUn double effet antiviral des IFITM sur les virus enveloppés
Jégado, B., Journo, C., & Mahieux, R. (2018) · médecine/sciences · doi:10.1051/medsci/20183403008 · Cited by 1
Role of rhesus macaque IFITM3(2) in simian immunodeficiency virus infection of macaques
Winkler, M., Gärtner, S., Markus, L., Hoffmann, M., Nehlmeier, I., Krawczak, M., Sauermann, U., & Pöhlmann, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224082 · Cited by 1
Unali, G., Giordano, A. M. S., Cuccovillo, I., Alezz, M. A., Apolonia, L., Merelli, I., Malim, M. H., Petrillo, C., & Kajaste‐Rudnitski, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.06.438585 · Cited by 1
Tauzin, A. (2020) · theses.fr (ABES) · doi:10.70675/47aaa60dz2c00z416bz83c6z64326da6c3dc · Cited by 1
Bonaventure, B. (2020) · theses.fr (ABES) · doi:10.70675/768c3190z3177z4b25z88b9z9a029e425462 · Cited by 1
Gene duplication and retrotransposition diversify the antiviral repertoire of macaque IFITM proteinsPreprint
Kappala, D., Sauer, A., Atwood, E., Zhang, Y., Pimplapure, A., Bektas-Jolly, N., Gujjari, L., Chandra, K., Saini, Y., Yount, J. S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.11.731520 · Cited by 1
Characterization and Reconstitution of S-Palmitoylated IFITM3 Antiviral Activity
Percher, A. (2018) · Digital Commons - RU (Rockefeller University) · doi:10.48496/tqgj-ye07
Membrane Microdomains as Platforms for Extra-Cellular Fusions
Hantak, M. P. (2019) · Loyola eCommons (Loyola University of Chicago)
de Jong, A. (2024) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/y1bc-vp35
Additional file 1 of Antiviral role of IFITM3 in prototype foamy virus infection
Wang, Z. W., Tuo, X., Zhang, J., Chai, K., Tan, J., & Qiao, W. (2022) · Figshare · doi:10.6084/m9.figshare.21622197
Identifying biophysical determinants of virus-cell fusion through live-cell imaging
Coomer, C. A. (2021) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-aenoovaj2
Caractérisation des activités antivirales des anticorps anti-VIH-1 et anti-SARS-CoV-2
Dufloo, J. (2021) · theses.fr (ABES) · doi:10.70675/215798eaz7f82z4e57za8eazf4453d37b8c8
Armani-Tourret, M. (2021) · theses.fr (ABES) · doi:10.70675/5ed5ae57z0e50z4110zba11zb0f4871eadeb
Cantaloube-Ferrieu, V. (2023) · theses.fr (ABES) · doi:10.70675/e7422723z7cb9z4feczba3bz407046e4c995
Contribution of endosomal proteins EHD1 and EHD4 to the HIV ‐1 replication cycle
Pacini, G., Poalas, K., Versapuech, M., Berlioz‐Torrent, C., & Janvier, K. (2026) · FEBS Journal · doi:10.1111/febs.70639
Song, Y., Xia, T., Martin, C., Després, G., Burlaud‐Gaillard, J., Lamazière, A., Roingeard, P., & Cimarelli, A. (2026) · Journal of Virology · doi:10.1128/jvi.01378-26
Self-citationValeri, E. (n.d.) · Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele
HIV-1 envelope glycan loss links receptor adaptation and innate immune escape in SHIVsPreprint
Smith, A., Weight, H., Katte, R., Kappala, D., Pimplapure, A., Prasad, V. M., Lu, M., Overbaugh, J., & Sharma, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.12.758606
Mak, N. S. C., Liu, J., Zhang, D., Taylor, J., Li, X., Rahman, K., Chen, F., Datta, S. A. K., Lai, K. K., Shi, Z., et al. (2024) · doi:10.1371/journal.ppat.1012763.r003
Metadata
- Authors
- Tartour, K., Nguyen, X.-N., Appourchaux, R., Assil, S., Barateau, V., Bloyet, L.-M., Burlaud Gaillard, J., Confort, M.-P., Escudero-Perez, B., Gruffat, H., Hong, S. S., Moroso, M., Reynard, O., Reynard, S., Decembre, E., Ftaich, N., Rossi, A., Wu, N., Arnaud, F., Baize, S., Dreux, M., Gerlier, D., Paranhos-Baccala, G., Volchkov, V., Roingeard, P., & Cimarelli, A.
- Affiliations
- Lyon 1 Université (FR)
- Université de Tours (FR)
- Corresponding author
- Cimarelli, Andrea
- ORCID
- Assil, Sonia
- Barateau, Véronique
- Bloyet, Louis-Marie
- Confort, Marie-Pierre
- Gruffat, Henri
- Hong, Saw See
- Moroso, Marie
- Reynard, Olivier
- Reynard, Stéphanie
- Rossi, Axel
- Wu, Nannan
- Arnaud, Frédérick
- Baize, Sylvain
- Dreux, Marlène
- Gerlier, Denis
- Paranhos-Baccala, Glaucia
- Volchkov, Viktor
- Roingeard, Philippe
- Cimarelli, Andrea
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-09-28
- Volume
- 13
- Issue
- 9
- Pages
- e1006610
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC5619827
- OpenAlex
- W2759331290
- Cited by
- 69
- References
- 93
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 10 · 2023: 6 · 2022: 5 · 2021: 14 · 2020: 8 · 2019: 7 · 2018: 10 · 2017: 1
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Fondation Innovations en Infectiologie
- Sidaction
- Agence Nationale de la Recherche (ANR-14-EBOL-0002)
- Deutsches Primatenzentrum
- Institut National de la Recherche Agronomique
- Université de Lyon
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- interferon-induced transmembrane proteins, IFITM3, HIV-1, viral infectivity, viral assembly, host restriction factors, viral receptor, viral replication inhibition, broad-spectrum antiviral activity
- MeSH terms
- Antigens, Differentiation, Cell Line, Humans, Virion, Virus Replication, HIV-1, Virus Internalization, Host-Pathogen Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.